Parrott N R, Lennard T W, Taylor R M, Proud G, Shenton B K, Johnston I D
Br J Surg. 1986 Dec;73(12):970-3. doi: 10.1002/bjs.1800731208.
The aim of the present study was to examine the outcome of 517 patients undergoing curative surgery for colonic and rectal cancer, and to compare the recurrence and mortality rates in transfused and non-transfused groups of patients. The two groups were evenly matched for age, sex, Dukes' stage and histological differentiation. There were significantly more rectal tumours in the transfused group (P less than 0.01), but the distribution of colonic lesions did not differ. Life table analysis revealed that the transfused patients had a 20 per cent greater probability of recurrence at 5 years (P less than 0.005) and there were 16 per cent more cancer related deaths (P less than 0.01). Even when all rectal cancers were excluded, a similar trend was seen for the colonic lesions: a 24 per cent greater probability of recurrence at 5 years (P less than 0.025) and 15 per cent more cancer related deaths (P less than 0.02). We conclude that blood transfusion may be associated with increased mortality and recurrence in patients undergoing curative surgery for colorectal cancer.
本研究的目的是检查517例接受结肠癌和直肠癌根治性手术患者的治疗结果,并比较输血组和未输血组患者的复发率和死亡率。两组在年龄、性别、杜克分期和组织学分化方面均衡匹配。输血组的直肠肿瘤明显更多(P<0.01),但结肠病变的分布没有差异。生命表分析显示,输血患者5年复发概率高20%(P<0.005),癌症相关死亡多16%(P<0.01)。即使排除所有直肠癌,结肠病变也有类似趋势:5年复发概率高24%(P<0.025),癌症相关死亡多15%(P<0.02)。我们得出结论,输血可能与接受结直肠癌根治性手术患者的死亡率和复发率增加有关。